MTOR (French Wikipedia)

Analysis of information sources in references of the Wikipedia article "MTOR" in French language version.

Last modified: 05:48:03, 28 August 2026 (UTC)

Ref.Un. Ref.Website

Global rank French rank

2922nih.gov

5^th place

11^th place

33doi.org

2^nd place

3^rd place

31genesdev.org

low place

11sciencedirect.com

137^th place

99^th place

11sciencemag.org

1,019^th place

299^th place

11healthvalue.net

low place

doi.org (Global: 2^nd place; French: 3^rd place)

dx.doi.org

Théo Ribierre, « Le mosaïcisme somatique en cause dans les épilepsies neurodéveloppementales / A second-hit somatic mutation drives neurodevelopmental epilepsy », Med Sci, vol. Volume 35, n^o Number 4,‎ 2019, p. 289 - 291 (PMID 31038102, DOI 10.1051/medsci/2019058, lire en ligne)
Ham DJ, Börsch A, Lin S, et al., « The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia », Nature Communications, vol. 11, 2020, article 4510 (PubMed 32908143, DOI 10.1038/s41467-020-18140-1)

doi.org

Théo Ribierre, « Le mosaïcisme somatique en cause dans les épilepsies neurodéveloppementales / A second-hit somatic mutation drives neurodevelopmental epilepsy », Med Sci, vol. Volume 35, n^o Number 4,‎ 2019, p. 289 - 291 (PMID 31038102, DOI 10.1051/medsci/2019058, lire en ligne)

genesdev.org (Global: low place; French: low place)

(en) Hay N, Sonenberg N, « Upstream and downstream of mTOR », Genes Dev, vol. 18, n^o 16,‎ 2004, p. 1926-45 (PMID 15314020, lire en ligne)

healthvalue.net (Global: low place; French: low place)

« "AKT, ILGF & Wnt pathways" at healthvalue.net » (consulté le 12 juillet 2007)

nih.gov (Global: 5^th place; French: 11^th place)

ncbi.nlm.nih.gov

(en) Hay N, Sonenberg N, « Upstream and downstream of mTOR », Genes Dev, vol. 18, n^o 16,‎ 2004, p. 1926-45 (PMID 15314020, lire en ligne)
(en) Beevers C, Li F, Liu L, Huang S, « Curcumin inhibits the mammalian target of rapamycin-mediated signaling pathways in cancer cells », Int J Cancer, vol. 119, n^o 4,‎ 2006, p. 757-64 (PMID 16550606)
(en) Guertin DA, Sabatini DM, « Defining the role of mTOR in cancer. », Cancer cell, vol. 12, n^o 1,‎ 2007, p. 9-22 (PMID 17613433, lire en ligne)
(en) Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ, « Hypothalamic mTOR signaling regulates food intake. », Science, vol. 312, n^o 5775,‎ 2006, p. 927-930 (PMID 16690869, lire en ligne)
Théo Ribierre, « Le mosaïcisme somatique en cause dans les épilepsies neurodéveloppementales / A second-hit somatic mutation drives neurodevelopmental epilepsy », Med Sci, vol. Volume 35, n^o Number 4,‎ 2019, p. 289 - 291 (PMID 31038102, DOI 10.1051/medsci/2019058, lire en ligne)
(en) Tokunaga C, Yoshino K, Yonezawa K, « mTOR integrates amino acid- and energy-sensing pathways », Biochem Biophys Res Commun, vol. 313, n^o 2,‎ 2004, p. 443-6 (PMID 14684182)
(en) Huang S, Houghton P, « Mechanisms of resistance to rapamycins », Drug Resist Updat, vol. 4, n^o 6,‎ 2001, p. 378-91 (PMID 12030785)
(en) Huang S, Bjornsti M, Houghton P, « Rapamycins: mechanism of action and cellular resistance », Cancer Biol Ther, vol. 2, n^o 3,‎ 2003, p. 222-32 (PMID 12878853)
(en) Wullschleger S, Loewith R, Hall M, « TOR signaling in growth and metabolism », Cell, vol. 124, n^o 3,‎ 2006, p. 471-84 (PMID 16469695)
(en) Kim D, Sarbassov D, Ali S, King J, Latek R, Erdjument-Bromage H, Tempst P, Sabatini D, « mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery », Cell, vol. 110, n^o 2,‎ 2002, p. 163-75 (PMID 12150925)
(en) Kim D, Sarbassov D, Ali S, Latek R, Guntur K, Erdjument-Bromage H, Tempst P, Sabatini D, « GbetaL, a positive regulator of the rapamycin-sensitive pathway required for the nutrient-sensitive interaction between raptor and mTOR », Mol Cell, vol. 11, n^o 4,‎ 2003, p. 895-904 (PMID 12718876)
(en) Fang Y, Vilella-Bach M, Bachmann R, Flanigan A, Chen J, « Phosphatidic acid-mediated mitogenic activation of mTOR signaling », Science, vol. 294, n^o 5548,‎ 2001, p. 1942-5 (PMID 11729323)
(en) Inoki K, Zhu T, Guan KL, « TSC2 mediates cellular energy response to control cell growth and survival. », Cell, vol. 115, n^o 5,‎ 2003, p. 577-90 (PMID 14651849)
(en) Frias M, Thoreen C, Jaffe J, Schroder W, Sculley T, Carr S, Sabatini D, « mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s », Curr Biol, vol. 16, n^o 18,‎ 2006, p. 1865-70 (PMID 16919458)
(en) Sarbassov D, Ali S, Kim D, Guertin D, Latek R, Erdjument-Bromage H, Tempst P, Sabatini D, « Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton », Curr Biol, vol. 14, n^o 14,‎ 2004, p. 1296-302 (PMID 15268862)
(en) Sarbassov D, Guertin D, Ali S, Sabatini D, « Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex », Science, vol. 307, n^o 5712,‎ 2005, p. 1098-101 (PMID 15718470)
(en) Stephens L, Anderson K, Stokoe D, Erdjument-Bromage H, Painter G, Holmes A, Gaffney P, Reese C, McCormick F, Tempst P, Coadwell J, Hawkins P, « Protein kinase B kinases that mediate phosphatidylinositol 3,4,5-trisphosphate-dependent activation of protein kinase B », Science, vol. 279, n^o 5351,‎ 1998, p. 710-4 (PMID 9445477)

pubmed.ncbi.nlm.nih.gov

Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim DH, « ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery », Mol Biol Cell, vol. 20, n° 7, 2009, p. 1992-2003 (PubMed 19225151)
Kim YC, Guan KL, « mTOR: a pharmacologic target for autophagy regulation », J Clin Invest, vol. 125, n° 1, 2015, p. 25-32 (PubMed 25654547)
Ham DJ, Börsch A, Lin S, et al., « The neuromuscular junction is a focal point of mTORC1 signaling in sarcopenia », Nature Communications, vol. 11, 2020, article 4510 (PubMed 32908143, DOI 10.1038/s41467-020-18140-1)
Areta JL, et al., « The response of muscle protein synthesis following whole-body resistance exercise is greater following 40 g than 20 g of ingested whey protein », Physiol Rep, vol. 4, n° 15, 2016 (PubMed 27587776).(en) Reidy PT, Rasmussen BB, « Protein timing and its effects on muscular hypertrophy and strength in individuals engaged in weight-training », Adv Nutr, vol. 7, n° 1, 2016, p. 197-201 (PubMed 26773025)
Ato S, et al., « Resistance exercise enhances long-term mTORC1 sensitivity to leucine », Mol Metab, vol. 66, 2022, article 101615 (PubMed 36372223)

sciencedirect.com (Global: 137^th place; French: 99^th place)

(en) Guertin DA, Sabatini DM, « Defining the role of mTOR in cancer. », Cancer cell, vol. 12, n^o 1,‎ 2007, p. 9-22 (PMID 17613433, lire en ligne)

sciencemag.org (Global: 1,019^th place; French: 299^th place)

(en) Cota D, Proulx K, Smith KA, Kozma SC, Thomas G, Woods SC, Seeley RJ, « Hypothalamic mTOR signaling regulates food intake. », Science, vol. 312, n^o 5775,‎ 2006, p. 927-930 (PMID 16690869, lire en ligne)